Clinical trial
Combination Chemotherapy in Treating Patients With Solid Tumors
NCT00009932 · Ohio State University Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00009932 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Solid Tumors |
| Official title | A Phase I Study Of Fenretinide Combined With Paclitaxel And Cisplatin For The Treatment Of Refractory Solid Tumors |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, fenretinide, paclitaxel |
| Start date | Jan 1, 2001 |
| First posted | Jun 6, 2003 |
| Last update posted | May 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: